Phase 2, Proof-of-Concept, Randomized, Double-blinded, Placebo-controlled, Multicenter Study to Assess Efficacy and Safety of Reparixin as Add-on Therapy to Standard of Care in Adult Patients With Acu

Activity Type
Clinical Trial
Date
Dollar Amount
*
Grant Type
Contract
Principal Investigator
Esa Rayyan
Sponsor
IQVIA RDS Inc.
Unit
COM Phx Internal Medicine